Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Neoplasms × Morphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 14 Pain 13 Pain, Postoperative 12 Cancer Pain 10 Agnosia 7 Chronic Pain 6 Colorectal Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms 4 Neoplasm Metastasis 3 Mucositis 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Supratentorial Neoplasms 2 Pancreatic Neoplasms 2 Pain, Intractable 2 Neoplastic Cells, Circulating 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Inflammation 2 Ileus 2 Hematologic Neoplasms 2 Wounds and Injuries 1 Waldenstrom Macroglobulinemia 1 Vesico-Ureteral Reflux 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1

Interventions

Sorafenib 42 Bevacizumab 26 Oxaliplatin 21 Radiosurgery 19 Gemcitabine 17 Fluorouracil 15 lenvatinib 12 Hepatectomy 12 Radiofrequency Ablation 11 Nivolumab 11 Cisplatin 11 Radiotherapy 10 Doxorubicin 10 Capecitabine 10 durvalumab 9 Leucovorin 9 Blood Specimen Collection 9 atezolizumab 8 Liver Transplantation 8 Everolimus 7 Electroporation 7 pembrolizumab 6 camrelizumab 6 Sunitinib 6 Immunohistochemistry 6 Cyclophosphamide 6 Cryosurgery 6 Carboplatin 6 tremelimumab 5 sintilimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03715517 2026-02-05

SAFER-L

University of Manitoba

Phase NA Recruiting

Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡